Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Large Cap Fund median (35 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 12 Aug 2022 – 20 Aug 2026, limited by quant Large Cap Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | quant Large Cap Fund | Nifty 100 |
|---|---|---|
| 12 Aug 2022 | ₹100.00 | ₹100.00 |
| 12 Dec 2022 | ₹104.19 | ₹104.09 |
| 14 Apr 2023 | ₹95.56 | ₹98.21 |
| 14 Aug 2023 | ₹108.96 | ₹107.65 |
| 15 Dec 2023 | ₹126.31 | ₹120.26 |
| 15 Apr 2024 | ₹149.24 | ₹127.90 |
| 16 Aug 2024 | ₹159.94 | ₹142.44 |
| 16 Dec 2024 | ₹157.83 | ₹142.86 |
| 17 Apr 2025 | ₹144.59 | ₹135.98 |
| 18 Aug 2025 | ₹155.34 | ₹141.96 |
| 18 Dec 2025 | ₹158.77 | ₹146.60 |
| 20 Apr 2026 | ₹155.73 | ₹140.63 |
| 20 Aug 2026 | ₹168.94 | ₹141.41 |
| Metric | quant · Direct NAV ₹16.91 Very High risk ★★★☆☆ | Category median Large Cap Fund · 35 funds |
|---|---|---|
| +7.57% | +0.75% | |
| +15.44% | +12.33% | |
| — | +11.21% | |
| — | +12.51% | |
| +13.93% | +13.22% | |
| +12.55% | — | |
| +16.45% | +14.61% | |
| — | +13.78% | |
| — | +13.95% | |
| Risk | ||
| 15.97% | 13.24% | |
| 0.56 | 0.43 | |
| 0.78 | 0.58 | |
| -21.11% | -35.14% | |
| Nifty 100 | — | |
| +4.94% | +2.33% | |
| 1.13 | 0.96 | |
| 121.1% | 103.3% | |
| 99.5% | 91.0% | |
| 1.49% | 1.07% | |
| ₹3,172Cr | ₹2,004Cr | |
| 1.00% | — | |
| None | — | |
| ₹1.00K | — | |
| ₹5.00K | — | |
| — | 50% | |
| Sanjeev Sharma | — | |
| 12 Aug 2022 | — | |
| 11 | — | |
| 71.0% | — | |
| 1.0% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.